Nausheen Ahmed
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Nausheen Ahmed
Jun 24, 2024, 22:06 |
Blog
Nausheen Ahmed: Approvals, toxicity and access updates on CART
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
May 22, 2024, 06:44 |
Insight
Nausheen Ahmed: A deeper look at social determinants of health and CAR-T
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
May 21, 2024, 13:21 |
Insight
Rahul Banerjee: Two-for-one with new MMsm articles in press in Transplantation and Cellular Therapy Journal
Rahul Banerjee, Assistant Professor in the Division of Medical Oncology at the University of Washington, shared…
Apr 5, 2024, 15:18 |
Career
Al-Ola Abdallah: A big congratulations to our esteemed colleagues, Drs. Male, Ahmed and Mushtaq for promotions
Al-Ola Abdallah, Plasma Cell Disorder Program Director of Division of HMCT/University of Kansas Medical Center,…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube